HCA Healthcare, Inc. $HCA Shares Sold by Community Trust & Investment Co.

Key Points

• Community Trust & Investment Co. reduced its stake in HCA Healthcare by 11.7% in the second quarter, now holding shares valued at $13.76 million.
• Recent insider activity includes EVP Michael S. Cuffe selling 3,836 shares for approximately $1.61 million, leading to a 10.85% decrease in their ownership.
• HCA Healthcare declared a quarterly dividend of $0.72 per share, implying an annualized yield of 0.7% and a dividend payout ratio of 12.11%.

Community Trust & Investment Co. decreased its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 11.7% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,919 shares of the company's stock after selling 4,744 shares during the quarter. Community Trust & Investment Co.'s holdings in HCA Healthcare were worth $13,761,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in HCA. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its stake in HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company's stock worth $8,796,000 after purchasing an additional 2,698 shares during the last quarter. Brown Advisory Inc. lifted its stake in HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company's stock worth $1,600,000 after purchasing an additional 1,622 shares during the last quarter. Farther Finance Advisors LLC increased its position in HCA Healthcare by 26.9% during the first quarter. Farther Finance Advisors LLC now owns 1,141 shares of the company's stock worth $395,000 after buying an additional 242 shares during the period. Oppenheimer Asset Management Inc. increased its position in HCA Healthcare by 2.5% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,314 shares of the company's stock worth $1,491,000 after buying an additional 105 shares during the period. Finally, GAMMA Investing LLC increased its position in HCA Healthcare by 17.6% during the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company's stock worth $1,704,000 after buying an additional 737 shares during the period. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Up 0.2%

HCA Healthcare stock traded up $1.00 during trading on Friday, hitting $402.06. The company's stock had a trading volume of 4,308,470 shares, compared to its average volume of 1,077,287. The stock has a market capitalization of $94.08 billion, a price-to-earnings ratio of 16.90, a P/E/G ratio of 1.26 and a beta of 1.41. The stock's fifty day moving average is $385.21 and its 200 day moving average is $365.77. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $420.98. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm's revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the firm posted $5.50 earnings per share. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a $0.72 dividend. The ex-dividend date of this dividend is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. HCA Healthcare's dividend payout ratio is currently 12.11%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Morgan Stanley dropped their target price on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Cantor Fitzgerald reissued an "overweight" rating and issued a $444.00 target price on shares of HCA Healthcare in a report on Tuesday, August 26th. Bank of America boosted their target price on HCA Healthcare from $375.00 to $410.00 and gave the company a "neutral" rating in a report on Wednesday, September 10th. Royal Bank Of Canada dropped their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a report on Monday, July 28th. Finally, JPMorgan Chase & Co. upped their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $407.75.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.